Follicular Lymphoma — Trials

Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

775 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 216
Recruiting: 107
Ph III recruiting: 10
Growth YoY: −8.6%
Industry share: 29%
Top sponsor: City of Hope Medical Center
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (149)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02966730	Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy	terminated	Early Phase 1	2	Memorial Sloan Kettering Cancer CenterOTHER	1	May 13, 2025	clinicaltrials
NCT03585725	A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma	terminated	Early Phase 1	3	Weill Medical College of Cornell UniversityOTHER	1	Sep 27, 2021